National Institute of Neurological Disorders and Stroke; Notice of Meetings, 21802-21803 [05-8416]

Download as PDF 21802 Federal Register / Vol. 70, No. 80 / Wednesday, April 27, 2005 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Diabetes and Digestive and Kidney Disease; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individual associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel. ZDK1 GRB–7 (C1) Date: May 11, 2005. Time: 8:30 a.m. to 9:30 a.m. Agenda: To review and evaluate contract proposals. Place: Bethesda, Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Lakshmanan Sankaran, PhD, Scientific Review Administrator, Review Branch, DEA, NIDDK, National Institutes of Health, Room 777, 6707 Democracy Boulevard, Bethesda, MD 20892– 5452, (301) 594–7799, Is38oz@nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel. ZDK1 GRB–7 (C2). Date: May 11, 2005. Time: 9:30 a.m. to 10:30 a.m. Agenda: To review and evaluate contract proposals. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Lakshmanan Sankaran, PhD, Scientific Review Administrator, Review Branch, DEA, NIDDK, National Institutes of Health, Room 777, 6707 Democracy Boulevard, Bethesda, MD 20892– 5452, (301) 594–7799, Is38oz@nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Disease and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) VerDate jul<14>2003 16:41 Apr 26, 2005 Jkt 205001 Dated: April 19, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–8413 Filed 4–26–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel 2 Challenge Grants: Biodefense Product Development RFA–A1– 04–029. Date: May 6, 2005. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Double Tree Rockville, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Tracy A. Shahan, PhD, Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID/NIH/DHHS, Room 3121, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, (301) 451–2606, tshahan@niaid.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: April 19, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–8415 Filed 4–26–05; 8:45 am] BILLING CODE 4140–01–M PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the National Advisory Neurological Disorders and Stroke Council. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Neurological Disorders and Stroke Council Training, Career Development, and Special Programs Subcommittee. Date: May 25, 2005. Open: 8 a.m. to 9:30 a.m. Agenda: To discuss the training programs of the Institute. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Diplomat/Ambassador Room, Bethesda, MD 20814. Closed: 9:30 p.m. to 10 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Diplomat/Ambassador Room, Bethesda, MD 20814. Contact Person: Margaret Jacobs, Acting Training and Special Programs Officer, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 6001 Executive Blvd., Suite 2154 MSC 9527, Bethesda, MD 20892–9527, 301–496–4188, mj22o@nih.gov. Name of Committee: National Advisory Neurological Disorders and Stroke Council Clinical Trials Subcommittee. Date: May 26, 2005. Open: 8 a.m. to 9 a.m. Agenda: To discuss clinical trials policy. E:\FR\FM\27APN1.SGM 27APN1 Federal Register / Vol. 70, No. 80 / Wednesday, April 27, 2005 / Notices Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Closed: 9 a.m. to 10 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Contact Person: John Marler, MD, Associate Director of Clinical Trials, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 6001 Executive Blvd., Suite 2216, Bethesda, MD 20892, (301) 496–9135, jm137f@nih.gov. Name of Committee: National Advisory Neurological Disorders and Stroke Council Basic and Preclinical Programs Subcommittee. Date: May 26, 2005. Open: 8 a.m. to 9:30 a.m. Agenda: To discuss basic and preclinical programs policy. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 8A28, Bethesda, MD 20892. Closed: 9:30 a.m. to 10 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 8A28, Bethesda, MD 20892. Contact Person: Robert Baughman, MD, Associate Director for Technology Development, National Institute for Neurological Disorders and Stroke, National Institutes of Health, 6001 Executive Blvd., Suite 2137, MSC 9527, Bethesda, MD 20892– 9527, (301) 496–1779. Name of Committee: National Advisory Neurological Disorders and Stroke Council. Date: May 26–27, 2005. Open: May 26, 2005, 10:30 a.m. to 5 p.m. Agenda: Report by the Director, NINDS; Report by the Director, Division of Extramural Research and other administrative and program developments. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Closed: May 27, 2005, 8 a.m. to 11:30 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room 10, Bethesda, MD 20892. Contact Person: Robert Finkelstein, PhD, Associate Director for Extramural Research, National Institute of Neurological Disorders and Stroke, NIH, 6001 Executive Blvd., Suite 3309, MSC 9531, Bethesda, MD 20892, (301) 496–9248. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance into the building by non-government employees. Persons without a government I.D. will need to show a photo I.D. and signin at the security desk upon entering the building. VerDate jul<14>2003 16:41 Apr 26, 2005 Jkt 205001 Information is also available on the Institute’s/Center’s home page: https:// www.ninds.nih.gov, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: April 19, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–8416 Filed 4–26–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Clinical and Data Management Services for NIDA/ DPMC. Date: May 4, 2005. Time: 9 a.m. to 4:30 p.m. Agenda: To review and evaluate contract proposals. Place: Holiday Inn Select Bethesda, 8120 Wisconsin Ave., Bethesda, MD 20814. Contact Person: Eric Zatman, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892– 8401. (301) 435–1438 This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug Abuse Scientist Development Award for Clinicians, Scientist Development Awards, and Research Scientist Awards; 93.278, Drug Abuse National Research Service Awards for Research PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 21803 Training; 93.279, Drug Abuse Research Programs, National Institutes of Health, HHS) Dated: April 19, 2005. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–8417 Filed 4–26–05; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of the National Advisory Council for Biomedical Imaging and Biogengineering. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council for Biomedical Imaging and Bioengineering. Date: May 25–26, 2005. Open: May 26, 2005, 8 a.m. to 11:30 a.m. Agenda: Presentation by the Institute Director and Executive Secretary. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892. Closed: May 26, 2005, 11:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892. Contact Person: Arlene Y. Chiu, PhD, Associate Director, Office of Research Administration, Office of Science Administration, National Institute of Biomedical Imaging and Bioengineering, 6707 Democracy Plaza, Suite 200, MSC– E:\FR\FM\27APN1.SGM 27APN1

Agencies

[Federal Register Volume 70, Number 80 (Wednesday, April 27, 2005)]
[Notices]
[Pages 21802-21803]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-8416]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the National 
Advisory Neurological Disorders and Stroke Council.
    The meetings will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Neurological Disorders and 
Stroke Council Training, Career Development, and Special Programs 
Subcommittee.
    Date: May 25, 2005.
    Open: 8 a.m. to 9:30 a.m.
    Agenda: To discuss the training programs of the Institute.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Diplomat/Ambassador Room, Bethesda, MD 20814.
    Closed: 9:30 p.m. to 10 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Diplomat/Ambassador Room, Bethesda, MD 20814.
    Contact Person: Margaret Jacobs, Acting Training and Special 
Programs Officer, National Institute of Neurological Disorders and 
Stroke, National Institutes of Health, 6001 Executive Blvd., Suite 
2154 MSC 9527, Bethesda, MD 20892-9527, 301-496-4188, mj22o@nih.gov.

    Name of Committee: National Advisory Neurological Disorders and 
Stroke Council Clinical Trials Subcommittee.
    Date: May 26, 2005.
    Open: 8 a.m. to 9 a.m.
    Agenda: To discuss clinical trials policy.

[[Page 21803]]

    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 10, Bethesda, MD 20892.
    Closed: 9 a.m. to 10 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 10, Bethesda, MD 20892.
    Contact Person: John Marler, MD, Associate Director of Clinical 
Trials, National Institute of Neurological Disorders and Stroke, 
National Institutes of Health, 6001 Executive Blvd., Suite 2216, 
Bethesda, MD 20892, (301) 496-9135, jm137f@nih.gov.

    Name of Committee: National Advisory Neurological Disorders and 
Stroke Council Basic and Preclinical Programs Subcommittee.
    Date: May 26, 2005.
    Open: 8 a.m. to 9:30 a.m.
    Agenda: To discuss basic and preclinical programs policy.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 8A28, Bethesda, MD 20892.
    Closed: 9:30 a.m. to 10 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 8A28, Bethesda, MD 20892.
    Contact Person: Robert Baughman, MD, Associate Director for 
Technology Development, National Institute for Neurological 
Disorders and Stroke, National Institutes of Health, 6001 Executive 
Blvd., Suite 2137, MSC 9527, Bethesda, MD 20892-9527, (301) 496-
1779.

    Name of Committee: National Advisory Neurological Disorders and 
Stroke Council.
    Date: May 26-27, 2005.
    Open: May 26, 2005, 10:30 a.m. to 5 p.m.
    Agenda: Report by the Director, NINDS; Report by the Director, 
Division of Extramural Research and other administrative and program 
developments.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 10, Bethesda, MD 20892.
    Closed: May 27, 2005, 8 a.m. to 11:30 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Building 31, 31 Center 
Drive, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Robert Finkelstein, PhD, Associate Director for 
Extramural Research, National Institute of Neurological Disorders 
and Stroke, NIH, 6001 Executive Blvd., Suite 3309, MSC 9531, 
Bethesda, MD 20892, (301) 496-9248.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance into the building by non-government 
employees. Persons without a government I.D. will need to show a 
photo I.D. and sign-in at the security desk upon entering the 
building.
    Information is also available on the Institute's/Center's home 
page: https://www.ninds.nih.gov, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)


    Dated: April 19, 2005.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-8416 Filed 4-26-05; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.